N@N

KG, TWTC, WCG, SF, ISIS, SWX Expected To Be Higher After Earnings Releases on Monday

^{Published on 2010-08-06 08:32:10, Last Modified on 2010-12-22 18:42:54 - WOPRAI}
 

August 6, 2010 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Monday, August 9th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and August earnings reports. King Pharmaceuticals (NYSE: KG), TW Telecom (NASDAQ: TWTC), Wellcare Health Plans (NYSE: WCG), Stifel Financial (NYSE: SF), Isis Pharmaceuticals (NASDAQ: ISIS) and Southwest Gas (NYSE: SWX) are all expected to be higher after their earnings are released Monday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go higher after earnings are released Monday:

Symbol Company # of Reports Quarter Release Time

KG King Pharmaceuticals August earnings Q2 Before

TWTC tw telecom inc 12 quarters Q2 After

WCG Wellcare Health Plans 12 quarters Q2 Before

SF Stifel Financial August earnings Q2 After

ISIS Isis Pharmaceuticals August earnings Q2 Before

SWX Southwest Gas Corp 12 quarters Q2 After

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

King Pharmaceuticals, Inc. (NYSE: KG) research and develops, manufactures, markets, and sells branded prescription pharmaceutical products and animal health products worldwide. It offers branded prescription pharmaceuticals, which include neuroscience products, such as Skelaxin, Flector Patch, Avinza, and Embeda; hospital products, including Thrombin-JMI; and legacy products consisting of Levoxyl, Bicillin, Altace, and Cytomel to general/family practitioners, internal medicine physicians, neurologists, pain specialists, surgeons, and hospitals. The companya�s animal health business focuses on medicated feed additives and water-soluble therapeutics, which are anti-infective products primarily for poultry, cattle, and swine markets. King Pharmaceuticals also manufactures and markets pharmaceutical products that are delivered using an auto-injector to commercial and government markets. Its auto-injector products include EpiPen, an auto-injector filled with epinephrine for the treatment of anaphylaxis resulting from severe or allergic reactions to insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; the nerve agent antidotes, including AtroPen and ComboPen; and the Antidote Treatment Nerve Agent Auto-injector. The company also licenses rights to third-party pharmaceutical companies to manufacture and market adenosine-based products, Adenoscan. Adenoscan is a sterile, intravenous solution of adenosine administered intravenously as an adjunct to imaging agents used in cardiac stress testing of patients. King Pharmaceuticals distributes its branded pharmaceutical products through wholesale pharmaceutical distributors, as well as animal health products through sales force. The company was founded in 1993 and is based in Bristol, Tennessee.

TW telecom inc. (NASDAQ: TWTC) provides managed network services to enterprise organizations and communication services companies in the United States. It offers Ethernet and transport data networking, Internet access, local and long distance voice, virtual private network (VPN), voice over Internet protocol, and network security services. The companya�s data services include point-to-point native local area network (NLAN), point-to-multipoint NLAN, multipoint NLAN, Regional Ethernet, customer-direct NLAN, switched NLAN, extended NLAN, Integrated NLAN, storage transport solutions, and Internet protocol VPN service. It also offers high capacity Internet service with bandwidth speeds ranging from 1.5 Mbps to 10 Gbps to access the Internet and other external networks. The companya�s network services enable voice, data, image, and video transmission, which include special access, private line, metropolitan and regional connectivity, and transport arrangements. tw telecoma�s voice services provide business customers with local and long distance calling capabilities, including business access line, access trunks, IP trunks, local toll service, local telephone service, long distance service, and bundled services. In addition, it offers intercarrier services, such as switched access service and local traffic termination services. The companya�s managed services comprise managed IP VPN, managed Internet, managed security services, and distributed denial of service mitigation. Its customers include enterprise organizations in the distribution, health care, finance, service and manufacturing industries; state, local, and federal government entities; system integrators; incumbent local exchange carriers; competitive local exchange carriers; wireless communications companies; and Internet service providers. The company was formerly known as Time Warner Telecom Inc. and changed its name to tw telecom inc. in March 2008. tw telecom was founded in 1993 and is headquartered in Littleton, Colorado.

WellCare Health Plans, Inc. (NYSE: WCG) provides managed care services for government-sponsored healthcare programs in the United States. The company offers Medicaid and Medicare plans, including health plans for families, children, aged, blind, and disabled, as well as prescription drug plans. Its Medicaid plans include plans for individuals who are dually eligible for Medicare and Medicaid; and beneficiaries of the Temporary Assistance to Needy Families program (TANF), Supplemental Security Income Program (SSI), ABD program, State Childrena�s Health Insurance program (S-CHIP), and the Family Health Plus program(FHP). The TANF program provides assistance to low-income families with children; the SSI and ABD program offers assistance to low-income aged, blind, and disabled individuals; and the S-CHIP and FHP programs provides assistance for families not eligible for Medicaid. Its Medicare plans include stand-alone prescription drug plans; and Medicare Advantage plans comprising coordinated care plans (CCP). The Medicare Advantage is Medicarea�s managed care alternative to original Medicare fee-for-service that provides individuals standard Medicare benefits through Centers for Medicare & Medicaid Services. CCPs are administered through a health maintenance organization and require members to seek health care services from a network of health care providers. As of December 31, 2009, WellCare Health Plans, Inc. had approximately 1,349,000 Medicaid members and approximately 972,000 Medicare members. The company was founded in 1985 and is headquartered in Tampa, Florida.

Stifel Financial Corp. (NYSE: SF), a financial holding company, operates as a retail and institutional brokerage, and investment banking company in the United States and internationally. Its Global Wealth Management segment provides securities brokerage services, including the sale of equities, mutual funds, fixed income products, and insurance and annuity products. This segment also offers retail and commercial banking services to private and corporate clients, including personal loan programs, such as fixed and variable mortgage loans, home equity lines of credit, personal loans, loans secured by CDs or savings, automobile loans, and securities-based loans; and commercial lending programs, such as small business loans, commercial real estate loans, lines of credit, credit cards, term loans, and inventory and receivables financing. As of December 31, 2009, it operated a network of 1,885 financial advisors, located in 272 branch offices in 42 states; and 166 independent contractors. The companya�s Capital Markets segment provides research, equity and fixed income institutional sales and trading, investment banking, public finance, and syndicate services. It distributes proprietary equity research products to institutional investors; provides financial advisory services principally with respect to mergers and acquisitions, and the execution of public offerings and private placements of debt and equity securities; and co-ordinates managed equity and debt offerings. The companya�s customers include individual investors, corporations, municipalities, and institutions. Stifel Financial Corp. was founded in 1890 and is headquartered in St. Louis, Missouri.

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) engages in the discovery and development of a new class of drugs called antisense drugs using antisense technology, a novel drug discovery platform to generate a broad pipeline of first-in-class drugs. It develops antisense drugs focused on treating cardiovascular, metabolic and severe neurodegenerative diseases, and cancer for systemic, local, and inhaled delivery. The company has commercialized antisense drugs and has 22 drugs in development. Isis Pharmaceuticals has strategic alliances with GlaxoSmithKline, Genzyme Corporation, Archemix Corp., and Alnylam Pharmaceuticals, Inc. The company was founded in 1989 and is based in Carlsbad, California.

Southwest Gas Corporation (NYSE: SWX) engages in the purchase, distribution, and transportation of natural gas in portions of Arizona, Nevada, and California. As of December 31, 2009, the company purchased and distributed, or transported natural gas to approximately 1,824,000 residential, commercial, and industrial customers. It also operates as an underground piping contractor that provides utility companies with trenching and installation, replacement, and maintenance services for energy distribution systems. The company was founded in 1931 and is headquartered in Las Vegas, Nevada.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641